Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 19;25(1):789.
doi: 10.1186/s12864-024-10697-1.

Sequencing by binding rivals SMOR error-corrected sequencing by synthesis technology for accurate detection and quantification of minor (< 0.1%) subpopulation variants

Affiliations

Sequencing by binding rivals SMOR error-corrected sequencing by synthesis technology for accurate detection and quantification of minor (< 0.1%) subpopulation variants

Christopher J Allender et al. BMC Genomics. .

Abstract

Background: Detecting very minor (< 1%) subpopulations using next-generation sequencing is a critical need for multiple applications, including the detection of drug resistant pathogens and somatic variant detection in oncology. A recently available sequencing approach termed 'sequencing by binding (SBB)' claims to have higher base calling accuracy data "out of the box." This paper evaluates the utility of using SBB for the detection of ultra-rare drug resistant subpopulations in Mycobacterium tuberculosis (Mtb) using a targeted amplicon assay and compares the performance of SBB to single molecule overlapping reads (SMOR) error corrected sequencing by synthesis (SBS) data.

Results: SBS displayed an elevated error rate when compared to SMOR error-corrected SBS and SBB techniques. SMOR error-corrected SBS and SBB technologies performed similarly within the linear range studies and error rate studies.

Conclusions: With lower sequencing error rates within SBB sequencing, this technique looks promising for both targeted and unbiased whole genome sequencing, leading to the identification of minor (< 1%) subpopulations without the need for error correction methods.

Keywords: Heteroresistance; NGS benchmarking; Sequencing by binding (SBB); Sequencing by synthesis (SBS); Single molecule overlapping reads (SMOR); Tuberculosis (TB); Ultra-rare mutation detection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Alignment of SBS, SBS-SMOR, and SBB reads for katG (A) and gyrA (B) Cartoon at the top of each IGV plot shows the relative position of the sequencing reads where SBS had both read 1 and read 2 each at 300 bps, while SBB has only read 1 from the 3’ end with variable lengths up to 150 bps long. Images in IGV are representatives of the the 10% proportion mixture and each read is colored grey, in squished mode, and are grouped by katG PCR position 224 (gene mutation: g944c) or gryA PCR position 197 (gene mutation: a241g). Mutations compared to the plasmid reference include single nucleotide variants, A(Green), G (Orange), C (Blue), T (Red), and N (Dark Grey)
Fig. 2
Fig. 2
Average observed % error rate (log 10) across gyrA and katG genes for comparable positions. The line represents the mean total error rate across samples at the specified position with a 95% confidence interval displayed as the lighter-colored ribbon

Update of

Similar articles

Cited by

  • Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair.
    McDaniel JH, Patel V, Olson ND, He HJ, He Z, Cole KD, Gooden AA, Schmitt A, Sikkink K, Sedlazeck FJ, Doddapaneni H, Jhangiani SN, Muzny DM, Gingras MC, Mehta H, Behera S, Paulin LF, Hastie AR, Yu HC, Weigman V, Rojas A, Kennedy K, Remington J, Salas-González I, Sudkamp M, Wiseman K, Lajoie BR, Levy S, Jain M, Akeson S, Narzisi G, Steinsnyder Z, Reeves C, Shelton J, Kingan SB, Lambert C, Baybayan P, Wenger AM, McLaughlin IJ, Adamson A, Kingsley C, Wescott M, Kim Y, Paten B, Park J, Violich I, Miga KH, Gardner J, McNulty B, Rosen GL, McCoy R, Brundu F, Sayyari E, Scheffler K, Truong S, Catreux S, Hannah LC, Lipson D, Benjamin H, Iremadze N, Soifer I, Krieger G, Eacker S, Wood M, Cross E, Husar G, Gross S, Vernich M, Kolmogorov M, Ahmad T, Keskus AG, Bryant A, Thibaud-Nissen F, Trow J, Proszynski J, Hirschberg JW, Ryon K, Mason CE, Bhakta MS, Sanborn JZ, Munding EM, Wagner J, Xiao C, Liss AS, Zook JM. McDaniel JH, et al. Sci Data. 2025 Jul 16;12(1):1195. doi: 10.1038/s41597-025-05438-2. Sci Data. 2025. PMID: 40670386 Free PMC article.
  • Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair.
    McDaniel JH, Patel V, Olson ND, He HJ, He Z, Cole KD, Gooden AA, Schmitt A, Sikkink K, Sedlazeck FJ, Doddapaneni H, Jhangiani SN, Muzny DM, Gingras MC, Mehta H, Behera S, Paulin LF, Hastie AR, Yu HC, Weigman V, Rojas A, Kennedy K, Remington J, Salas-González I, Sudkamp M, Wiseman K, Lajoie BR, Levy S, Jain M, Akeson S, Narzisi G, Steinsnyder Z, Reeves C, Shelton J, Kingan SB, Lambert C, Bayabyan P, Wenger AM, McLaughlin IJ, Adamson A, Kingsley C, Wescott M, Kim Y, Paten B, Park J, Violich I, Miga KH, Gardner J, McNulty B, Rosen GL, McCoy R, Brundu F, Sayyari E, Scheffler K, Truong S, Catreux S, Hannah LC, Lipson D, Benjamin H, Iremadze N, Soifer I, Krieger G, Eacker S, Wood M, Cross E, Husar G, Gross S, Vernich M, Kolmogorov M, Ahmad T, Keskus A, Bryant A, Thibaud-Nissen F, Trow J, Proszynski J, Hirschberg JW, Ryon K, Mason CE, Bhakta MS, Zachary Sanborn J, Munding EM, Wagner J, Xiao C, Liss AS, Zook JM. McDaniel JH, et al. bioRxiv [Preprint]. 2025 Jun 14:2024.09.18.613544. doi: 10.1101/2024.09.18.613544. bioRxiv. 2025. Update in: Sci Data. 2025 Jul 16;12(1):1195. doi: 10.1038/s41597-025-05438-2. PMID: 39345378 Free PMC article. Updated. Preprint.
  • Sequencing by Binding rivals error-corrected Sequencing by Synthesis technology for accurate detection and quantification of minor (<0.1%) subpopulation variants.
    Allender CJ, Wike C, Ellis D, Lemmer D, Porter T, Pond SJK, Engelthaler DM. Allender CJ, et al. Res Sq [Preprint]. 2024 May 21:rs.3.rs-4391713. doi: 10.21203/rs.3.rs-4391713/v1. Res Sq. 2024. Update in: BMC Genomics. 2024 Aug 19;25(1):789. doi: 10.1186/s12864-024-10697-1. PMID: 38826386 Free PMC article. Updated. Preprint.

References

    1. Manley LJ, Ma D, Levine SS. Monitoring error rates in Illumina sequencing. J Biomol Tech. 2016;27:125–8. 10.7171/jbt.16-2704-002 - DOI - PMC - PubMed
    1. Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J et al. The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. MBio. 2017;8. - PMC - PubMed
    1. Rinder H, Mieskes KT, Löscher T. Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2001;5:339–45. - PubMed
    1. Lee JH, Garg T, Lee J, McGrath S, Rosman L, Schumacher SG, et al. Impact of molecular diagnostic tests on diagnostic and treatment delays in tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2022;22:940. 10.1186/s12879-022-07855-9 - DOI - PMC - PubMed
    1. Soedarsono S, Mertaniasih NM, Hasan H, Kusmiati T, Permatasari A, Kusumaningrum D, et al. Line probe assay test in new cases of tuberculosis with rifampicin resistance not detected by Xpert MTB/RIF. Int J Mycobacteriol. 2022;11:429–34. 10.4103/ijmy.ijmy_176_22 - DOI - PubMed

MeSH terms

LinkOut - more resources